Scientist B, Department of Epidemiology, ICMR - National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Technical Officer, Department of Social and Behavioural Research, ICMR - National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Indian J Public Health. 2023 Apr-Jun;67(2):301-304. doi: 10.4103/ijph.ijph_899_22.
A pilot study with a mixed-methods design was conducted to estimate the time for tuberculosis (TB) treatment initiation and associated factors among children with central nervous system-TB (CNS-TB). A total of 38 children were enrolled for the quantitative component, and 20 in-depth interviews were conducted. The median duration (interquartile range) from onset of symptoms to treatment initiation was 23 (11, 55) days. About 44% and 31% of the children presented with Stage II and Stage III of CNS-TB, respectively. The major reasons for delay were symptoms not taken seriously (50%) and too many referrals (21%). About 89% of the families went into catastrophic health expenditure due to the disease. The treatment delay may be due to both patient delay and health system delay. Tailoring approaches to target the pediatric population could further improve early detection and treatment initiation of CNS-TB.
一项采用混合方法设计的初步研究旨在估计中枢神经系统结核(CNS-TB)患儿的结核病(TB)治疗开始时间及其相关因素。共有 38 名儿童参与了定量部分,20 名儿童接受了深入访谈。从症状出现到开始治疗的中位数(四分位间距)为 23(11,55)天。约 44%和 31%的患儿分别表现为 CNS-TB 的第二阶段和第三阶段。延迟的主要原因是症状未被重视(50%)和转诊过多(21%)。约 89%的家庭因该疾病而陷入灾难性的医疗支出。治疗延迟可能是由于患者延迟和卫生系统延迟。针对儿科人群制定的方法可以进一步改善 CNS-TB 的早期发现和治疗开始。